Furthermore, treatment with nodakenin contained in AGN extract was shown to ameliorate skin lesions in 2, 4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis in mice via suppressing IgE-mediated allergic responses [42]. This evidence concerns the gene IGHE and atopic eczema.